Chen Cheng
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Pharmacology top 2%
- Pharmacological Effects of Natural Compounds
Papers in
-
- Glycosylation and Glycoproteins Research 4
- Oncology 12
- CAR-T cell therapy research 5
- HER2/EGFR in Cancer Research 3
- Co-authors
- Haoyi Wang (4 shared papers)Xingying Zhang (3 shared papers)Na Li (3 shared papers)Xiaofei Wei (3 shared papers)Olajide E. Olaleye (9 shared papers)Junling Yang (7 shared papers)Chuan Li (8 shared papers)Weidong Han (3 shared papers)
- Journals
- Acta Pharmacologica Sinica (7 papers)Drug Metabolism and Disposition (3 papers)Journal of Biological Chemistry (3 papers)Journal of Structural Biology (2 papers)International Journal of Molecular Sciences (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Chen Cheng
48 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 110
- Oncology 594
- Pharmacology 148
- Complementary and alternative medicine 127
- Immunology 241
- Molecular Biology 632
Countries citing papers authored by Chen Cheng
This map shows the geographic impact of Chen Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Cheng more than expected).
Fields of papers citing papers by Chen Cheng
This network shows the impact of papers produced by Chen Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Cheng. The network helps show where Chen Cheng may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Cheng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 193 | |
| 2 | 2021 | 192 | |
| 3 | 2022 | 112 | |
| 4 | 2013 | 67 | |
| 5 | 2022 | 65 | |
| 6 | 2018 | 58 | |
| 7 | 2017 | 55 | |
| 8 | 2020 | 54 | |
| 9 | 2020 | 51 | |
| 10 | 2013 | 47 | |
| 11 | 2024 | 44 | |
| 12 | 2016 | 44 | |
| 13 | 2020 | 44 | |
| 14 | 2021 | 37 | |
| 15 | 2021 | 34 | |
| 16 | 2021 | 33 | |
| 17 | 2019 | 30 | |
| 18 | 2018 | 29 | |
| 19 | 2021 | 29 | |
| 20 | 2019 | 29 |
About Chen Cheng
Chen Cheng is a scholar working on Molecular Biology, Oncology, Complementary and alternative medicine, Immunology and Pharmacology, having authored 51 papers that have together received 1.6k indexed citations. Recurring topics across this work include Traditional Chinese Medicine Analysis (9 papers), Pharmacological Effects of Natural Compounds (6 papers), CAR-T cell therapy research (5 papers), Glycosylation and Glycoproteins Research (4 papers), Plant-based Medicinal Research (4 papers), Immune Cell Function and Interaction (4 papers), Phytochemistry and Biological Activities (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (594 citations), Pharmacology (148 citations), Complementary and alternative medicine (127 citations), Immunology (241 citations) and Molecular Biology (632 citations). Chen Cheng has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Haoyi Wang, Xingying Zhang, Na Li, Xiaofei Wei, Olajide E. Olaleye, Junling Yang, Chuan Li, Weidong Han, Weiwei Jia and Xuan Yu. Their work appears in journals such as Acta Pharmacologica Sinica, Drug Metabolism and Disposition, Journal of Biological Chemistry, Journal of Structural Biology and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.